To include your compound in the COVID-19 Resource Center, submit it here.

Liprotamase regulatory update

FDA issued a complete response letter for Eli Lilly's liprotamase to treat exocrine pancreatic insufficiency

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE